News & Updates

Patients with advanced melanoma achieve long-term survival with the use of pembrolizumab, as shown by the results of the 10-year follow-up of the phase III KEYNOTE-006 study.

In patients hospitalized for COVID-19, use of statins prior to admission is predictive of improved outcomes and lower inflammation, according to a study.

The incidence of prostate cancer is reduced among individuals treated with salbutamol, a short-acting beta-2 adrenergic agonist, according to a study.